PLEASANTON, Calif., March 14, 2016 (GLOBE NEWSWIRE) — At its annual meeting held on Monday, March 14, 2016 in Pleasanton, California, the stockholders of The Cooper Companies, Inc. (NYSE:COO) elected seven directors, ratified the appointment of KPMG LLP as the Company’s auditors for fiscal 2016 and approved the amendment and restatement of the 2007 Long-Term Incentive Plan. Stockholders also approved, on an advisory basis, the Company’s compensation practices for its executive officers.
BOARD OF DIRECTORS
Cooper’s stockholders elected the following as members of the board of directors: A. Thomas Bender, chairman of the board of the Company; Allan E. Rubenstein, M.D., vice-chairman of the board and lead director of the Company; Michael H. Kalkstein; Jody S. Lindell; Gary S. Petersmeyer; Robert S. Weiss, president and chief executive officer of the Company; and Stanley Zinberg, M.D.
About The Cooper Companies
The Cooper Companies, Inc. (“Cooper”) is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women’s health clinicians with market-leading products and treatment options to improve the delivery of health care to women. Headquartered in Pleasanton, CA, Cooper has approximately 10,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
CONTACT:
Kim Duncan
Vice President, Investor Relations
[email protected]
925-460-3663
